Supplements, measured to the milligram.
We treat a supplement the way a pharmacologist treats a drug: what the dose is, how much of it is absorbed, how long it stays in the body, and how the trial dose compares with the scoop in the tub.
Nine issues, dose by dose.
Half Life launched in the autumn of 2024 as the pharmacology title of VOL Collective, the independent editorial studio in New York. The first issue carried eight founder interviews, each closing with a dose box that set the label beside the trial.
We read the label, then the study the label is quietly leaning on, and we report the gap. We do not diagnose or prescribe, and we never mistake a mouse, a cell culture or an eight-person pilot for a result in a person. When the evidence holds up, we say that too.
Today 33,200 people read Half Life each month, most of them in the US, and 10,100 get The Friday Dose on Fridays. Seventy-four percent have looked up a dose in a study or a database before buying, and 62 percent take three or more supplements a day.
The people behind Half Life
Daniel Mercer
Publisher & Editorial Director
Natalie Hayes
Editor-in-Chief
Vivian Hart
Executive Editor
Ramin Vandi
Director of Features & PartnershipsDominic Rhodes
Managing EditorMackenzie Barrett
Deputy EditorLaura Quinn
Senior EditorNaomi Hardy
Commissioning EditorKelsey Lindqvist
Science EditorLeo Shepherd
Research EditorZoe Fallon
Fact-checkerSydney Grant
Contributing EditorAngela Delgado
Copy EditorMaya Vaughn
Associate EditorNathan Fleming
Photo EditorAmelia Thornton
Newsletter EditorKatherine Warren
Features EditorHailey Carson
Features EditorVictoria Hawkins
Features EditorHalf Life, year by year
- 2023
VOL Collective begins
VOL Collective publishes its first interview in New York. Our editors start asking supplement founders a question they rarely hear: which trial, and at what dose?
- 2024
Issue 01
Half Life launches in the autumn with eight founder interviews, each closing with a dose box that sets the label beside the trial.
- 2025
The Friday Dose
The Friday newsletter passes 7,000 subscribers, and our reader survey finds that 74 percent of readers have looked up a dose before buying.
- 2026
Issue 09 and the first Label Night
The monographs launch in July, starting with what a label actually gives you per scoop. With 33,200 readers a month, founders from this issue bring a label to the first Label Night, where a pharmacist and a trial statistician read it aloud with the audience.
